Sands Capital Ventures, LLC Acumen Pharmaceuticals, Inc. Transaction History
Sands Capital Ventures, LLC
- $235 Million
- Q1 2025
A detailed history of Sands Capital Ventures, LLC transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Sands Capital Ventures, LLC holds 3,417,075 shares of ABOS stock, worth $4.1 Million. This represents 1.6% of its overall portfolio holdings.
Number of Shares
3,417,075
Previous 3,417,075
-0.0%
Holding current value
$4.1 Million
Previous $5.88 Million
36.06%
% of portfolio
1.6%
Previous 2.23%
Shares
1 transactions
Others Institutions Holding ABOS
# of Institutions
83Shares Held
38.5MCall Options Held
39.1KPut Options Held
53.4K-
Ra Capital Management, L.P. Boston, MA14.9MShares$17.9 Million0.34% of portfolio
-
Franklin Resources Inc San Mateo, CA3.14MShares$3.77 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.16MShares$2.59 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.94MShares$2.32 Million0.0% of portfolio
-
Knollwood Investment Advisory, LLC Hunt Valley, MD1.63MShares$1.95 Million0.2% of portfolio
About Acumen Pharmaceuticals, Inc.
- Ticker ABOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,503,100
- Market Cap $48.6M
- Description
- Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...